Abstract:Cardiac fibrosis is the final common pathway of various heart diseases, characterized by excessive buildup of extracellular matrix proteins by fibroblasts in the myocardial interstitial compartments. Although the study of fibroblasts has been carried out for many years, the source of fibroblasts is still unclear. Recent reports suggest that about 1/3 of these interstitial fibroblasts are derived from the endothelial cells. It is a process in which endothelia lose their endothelial features but gain some mesenchymal phenotypes. The phenotypic switching, termed as endothelial mesenchymal transition (EndMT), becomes the focus of the current research in fibrosis diseases. In this review, we summarize the background knowledge of EndMT and then elucidate the evidence and mechanism of EndMT in cardiac fibrosis.

Endothelial Mesenchymal Transition in Cardiac Fibrosis